HTRS2025.P1.25 Efficacy and Safety of Fidanacogene Elaparvovec Gene Therapy in US Adults With Hemophilia B: A Subgroup Analysis of the BENEGENE-2 Gene Therapy Trial

Authors
Category Primary study
ConferenceResearch and Practice in Thrombosis and Haemostasis
Year 2025
This article has no abstract
Epistemonikos ID: 48b93bad32d8f8c365eef1b5ea0a4c57c0aaef53
First added on: Jan 10, 2026